Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousBone MarrowTransplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow CellsGraft vs Host DiseaseLymphocytesTransplantation ConditioningHematopoietic Stem Cell MobilizationWhole-Body IrradiationHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorGraft SurvivalBusulfanAnemia, AplasticCyclophosphamideTransplantation ChimeraLeukemiaTissue DonorsBone and BonesLeukapheresisHematologic NeoplasmsCombined Modality TherapyBone Marrow PurgingAntigens, CD34Histocompatibility TestingHistocompatibilityLiver TransplantationHematopoiesisT-LymphocytesRecurrenceTransplantation, IsogeneicBlood Component RemovalLymphocyte ActivationTreatment OutcomeStem CellsBone Marrow DiseasesMelphalanStem Cell TransplantationLymphoma, Non-HodgkinRemission InductionTime FactorsAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsLeukemia, Myeloid, AcuteBlood CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMultiple MyelomaMice, Inbred C57BLLymphocyte DepletionLeukocyte CountFlow CytometryKidney TransplantationEtoposidePrecursor Cell Lymphoblastic Leukemia-LymphomaBlood Cell CountLeukocyte TransfusionCord Blood Stem Cell TransplantationColony-Forming Units AssayTransplantation ImmunologyImmunosuppressionRadiation ChimeraRetrospective StudiesAcute DiseaseCells, CulturedLeukemia, MyeloidLymphocyte TransfusionSurvival AnalysisHLA AntigensBone Marrow ExaminationImmunophenotypingLeukocytes, MononuclearMyelodysplastic SyndromesCytarabineGraft RejectionHematologic DiseasesDisease-Free SurvivalHepatic Veno-Occlusive DiseaseCell SeparationSurvival RateCyclosporineLymphomaLymphocyte CountGraft vs Host ReactionAntigens, CDBone RemodelingCarmustineLymphocyte SubsetsInfectionCytomegalovirus InfectionsNuclear FamilyHodgkin DiseaseBone Marrow NeoplasmsChimeraFollow-Up StudiesSpleenCell DifferentiationB-Lymphocytes